Utilising a 15-month focused industry-led curriculum, The MedTech Actuator Accelerator Program takes Seed ventures to Series A investment; leading into clinical trials, advanced manufacturing, and at-scale technology deployment. Through intensive mentorship, industry collaboration, and value-network support, our startups can achieve in 15 months what can typically take 3 years or more.
We admit 20-40 start-ups into the Accelerator Program annually through two rounds (March & September), and with the support from corporate partners, prepare them for future capital raisings, clinical trials and market launch. Milestone momentum is rewarded with multiple capital injection points and the program is tightly linked to startup pathways across the globe. The expected outcome is a globally competitive medtech company that has raised $3M+ in Angel and Series A round funding, and is well underway in their clinical trials.
The program is structured as a 6-month intensive program, followed by 9-month mentor driven acceleration – delivered by industry leaders and aligned with global expectations. Startups have access to Australia’s largest MedTech investment community, and a pathway to $3 million+ (Seed to Series A).
